株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ナノエマルジョン市場:薬剤クラス別(ステロイド、麻酔剤、NSAID、免疫抑制剤、抗ウイルス剤、抗菌剤、その他)、投与ルート別、流通チャネル別-世界の業界分析、規模、シェア、成長、動向及び2017~2022年の予測

Nanoemulsion Market (Drug Class - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Other; Route of Administration; Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

発行 Transparency Market Research 商品コード 563608
出版日 ページ情報 英文 191 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.69円で換算しております。
Back to Top
ナノエマルジョン市場:薬剤クラス別(ステロイド、麻酔剤、NSAID、免疫抑制剤、抗ウイルス剤、抗菌剤、その他)、投与ルート別、流通チャネル別-世界の業界分析、規模、シェア、成長、動向及び2017~2022年の予測 Nanoemulsion Market (Drug Class - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Other; Route of Administration; Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
出版日: 2017年09月19日 ページ情報: 英文 191 Pages
概要

ナノエマルジョンに基づく薬剤は標的部位における薬剤分子のバイオアベイラビリティの高さから所定のドラッグデリバリーを標的とするのに用いられます。慢性疾患など様々な疾患を患う患者の治療に応用されています。

当レポートでは、世界のナノエマルジョン市場について調査し、市場の薬剤クラス別、投与ルート別、流通チャネル別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 序論

第2章 予測と調査方法

第3章 エグゼクティブサマリー

第4章 市場概要

  • 製品概要
  • 主な業界発展

第5章 市場動向

  • 促進因子と阻害因子分析
  • 機会分析
  • 主な動向
  • 市場収益予測
  • ポーターズファイブフォース分析
  • PEST分析
  • バリューチェーン分析
  • 市場の見通し

第6章 薬剤クラス別市場分析

  • 主な調査結果
  • イントロダクション
  • 市場価値シェア
  • 市場予測
  • 市場の魅力度分析

第7章 投与ルート別市場分析

  • 主な調査結果
  • イントロダクション
  • 市場価値シェア
  • 市場予測
  • 市場の魅力度分析

第8章 流通チャネル別市場分析

  • 主な調査結果
  • イントロダクション
  • 市場価値シェア
  • 市場予測
  • 市場の魅力度分析

第9章 地域別市場分析

  • 地理的シナリオ
  • イントロダクション
  • 市場価値シェア分析
  • 市場予測
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
  • 市場の魅力度分析

第10章 北米市場

第11章 欧州市場

第12章 アジア太平洋地域市場

第13章 ラテンアメリカ市場

第14章 中東・アフリカ市場

第15章 競合環境

  • 企業別市場シェア分析
  • 競合マトリクス
  • 企業プロファイル
    • AbbVie Inc.
    • Allergan plc.
    • AstraZeneca
    • Fresenius Kabi AG
    • 科研製薬株式会社
    • 田辺三菱製薬株式会社
    • NanoBio Corporation
    • Novartis AG
    • GlaxoSmithKline plc.
    • Sanofi
    • B. Braun Melsungen AG

図表

目次

Global Nanoemulsion Market: Overview

Nanoemulsion based drug products are used for target specific drug delivery as they provide increased bioavailability on the drug molecule at the target site. Nanoemulsion can be used for various applications in treating patients suffering from various disorders such as chronic. Nanoemulsion have been primarily classified into drug class segments: Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Vasodilators, and Others. Increasing prevalence of kidney diseases, growing prevalence of chronic diseases, increasing development of vaccines, and technological advancements along with aging population, high demand for minimally invasive procedures are few factors contributing to the growth of the market. The report comprises of an executive summary which delivers information about the nanoemulsion, its segments with market snapshot and comparative analysis by geography, in terms of revenue %, for 2016.

A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the Nanoemulsion market, along with porter's analysis, pest analysis value chain analysis, of the global market, has been provided in this report. Market revenue analysis for all the above mentioned segments has been provided for the forecast period of 2017-2025, considering 2016 as the base year, and 2015 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2017-2025. Market share estimations were based on in-depth analysis and study of products, and their features etc.

This report provides in-depth analysis of the Nanoemulsion market. The stakeholders for this report include companies involved in the manufacturing of Nanoemulsion. Executive summary section is included snapshot on stakeholders in this report, which summarizes the market size, trends and competition in different regions. Market players and Market share analysis is analyzed to signify percentage share of the major players operating in the Nanoemulsion market. Furthermore, the report includes market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2016.

The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of key opinion leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.

Global Nanoemulsion Market: Segmentation

Based on drug type, the Nanoemulsion market has been segmented into Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Vasodilators, and Others. NSAID drug class is growing at a CAGR of 9.8% from 2017 to 2025 due to increasing use in topical formulation. Based on Route of Administration the Nano emulsion market has been segmented into Topical, Oral, Parenteral, Nasal, Others. Based on Distribution channel Nanoemulsion market has been segmented into Hospital pharmacies, Retail pharmacies, and E-commerce.

Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further segmented into major countries which include, U.S., Canada, Germany, U.K., France, Italy, and Spain, rest of Europe, China, Japan, India, Australia, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, Saudi Arabia, South Africa, and Rest of Middle East & Africa.

Global Nanoemulsion Market: Competitive Landscape

The report also comprises list of major players in the market, their SWOT analysis, market share of these players in the Nanoemulsion market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Allergan plc. , AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, GlaxoSmithKline plc., Novartis AG, Sanofi, and B. Braun Melsungen AG.

The Nanoemulsion Market has been segmented as follows:

  • Nanoemulsion Market, by Drug Class
  • Steroids
  • Anesthetics
  • NSAIDs
  • Immunosuppressant
  • Antiretroviral
  • Antimicrobials
  • Vasodilators
  • Others
  • Nanoemulsion Market, by Route of Administration
  • Topical
  • Oral
  • Parenteral
  • Nasal
  • Others
  • Nanoemulsion Market, by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce
  • Nanoemulsion Market, by Geography
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East & Africa

Table of Contents

Section 1 Preface

  • 1.1 Report Scope and Market Segmentation
  • 1.2 Research Highlights

Section-2 Assumptions and Research Methodology

  • 2.1 Assumptions and Acronyms Used
  • 2.2 Research Methodology

Section-3 Executive Summary

  • 3.1 Global Nanoemulsion Market: Market Snapshot
  • 3.2 Global Nanoemulsion Market: Opportunity Map

Section-4 Market Overview

  • 4.1 Global Nanoemulsion Market: Product Overview
  • 4.2 Global Nanoemulsion Market: Key Industry Developments

Section-5 Market Dynamics

  • 5.1 Drivers and Restraints Snapshot Analysis
    • 5.1.2 Drivers
    • 5.1.3 Restraints
    • 5.1.4 Opportunity
  • 5.2 Opportunity Analysis
  • 5.3 Key Trends
  • 5.4 Global Nanoemulsion Market Revenue Forecast
  • 5.5 Porter's Five Forces Analysis
  • 5.6 PEST Analysis
  • 5.7 Value Chain Analysis
  • 5.8 Global Nanoemulsion Market Outlook

Section-6 Global Nanoemulsion Market Analysis, by Drug Class

  • 6.1 Key Findings
  • 6.2 Introduction
  • 6.3 Global Nanoemulsion Market Value Share Analysis, by Drug Class
  • 6.4 Global Nanoemulsion Market Forecast, by Drug Class
    • 6.4.1 Steroids
    • 6.4.2 Aesthetics
    • 6.4.3 NSAIDs
    • 6.4.4 Immunosuppressant
    • 6.4.5 Antiretroviral
    • 6.4.6 Antimicrobials
    • 6.4.7 Vasodilators
    • 6.4.8 Others
  • 6.5 Global Nanoemulsion Market Attractiveness Analysis, By Drug Class

Section-7 Global Nanoemulsion Market Analysis, by Route of Administration

  • 7.1 Key Findings
  • 7.2 Introduction
  • 7.3 Global Nanoemulsion Market Value Share Analysis, by Route of Administration
  • 7.4 Market Value (US$ Mn) Forecast By Route of Administration
    • 7.4.1 Topical
    • 7.4.2 Oral
    • 7.4.3 Parenteral
    • 7.4.4 Nasal
    • 7.4.5 Others
  • 7.5 Global Nanoemulsion Market Attractiveness Analysis, By Route of Administration

Section-8 Global Nanoemulsion Market Analysis, by Distribution Channel

  • 8.1 Key Findings
  • 8.2 Introduction
  • 8.3 Global Nanoemulsion Market Value Share Analysis, by Distribution Channel
  • 8.4 Market Value (US$ Mn) Forecast By Distribution Channel
    • 8.4.1 Hospital Pharmacies
    • 8.4.2 Retail Pharmacies
    • 8.4.3 E-Commerce
  • 8.5 Global Nanoemulsion Market Attractiveness Analysis, By Distribution Channel

Section-9 Global Nanoemulsion Market Analysis, by Region

  • 9.1 Geographical Scenario
  • 9.2 Introduction
  • 9.3 Nanoemulsion Market Value Share Analysis, by Region, 2017 and 2025
  • 9.4 Nanoemulsion Market Forecast, by Region
    • 9.4.1 North America
    • 9.4.2 Europe
    • 9.4.3 Asia Pacific
    • 9.4.4 Latin America
    • 9.4.1 Middle East & Africa
  • 9.5. Nanoemulsion Market Attractiveness Analysis, By Region, 2017 and 2025

Section-10 North America Nanoemulsion Market Analysis and Forecast

  • 10.1 Key Findings
  • 10.2 Market Value (US$ Mn) Forecast, By Country
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Market Value (US$ Mn) Forecast By Drug Class
  • 10.4 Market Value (US$ Mn) Forecast By Route of Administration
  • 10.5 Market Value (US$ Mn) Forecast By Distribution Channel
  • 10.6 Market Attractiveness Analysis
    • 10.6.1 By Country
    • 10.6.2 By Drug Class
    • 10.6.3 By Route of Administration
    • 10.6.4 By Distribution Channel

Section-11 Europe Nanoemulsion Market Analysis and Forecast

  • 11.1 Key Findings
  • 11.2 Market Value (US$ Mn) Forecast, By Country
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 U.K.
    • 11.2.4 Spain
    • 11.2.5 Italy
    • 11.2.6 Rest of Europe
  • 11.3 Market Value (US$ Mn) Forecast By Drug Class
  • 11.4 Market Value (US$ Mn) Forecast By Route of Administration
  • 11.5 Market Value (US$ Mn) Forecast By Distribution Channel
  • 11.6 Market Attractiveness Analysis
    • 11.4.1 By Country
    • 11.4.2 By Drug Class
    • 11.4.3 By Route of Administration
    • 11.4.4 By Distribution Channel

Sectin-12 Asia Pacific Nanoemulsion Market Analysis and Forecast

  • 12.1 Key Findings
  • 12.2 Market Value (US$ Mn) Forecast, By Country
    • 12.2.1 China
    • 12.2.2 Japan
    • 12.2.3 India
    • 12.2.4 Australia
    • 12.2.5 Rest of APAC
  • 12.3 Market Value (US$ Mn) Forecast By Drug Class
  • 12.4 Market Value (US$ Mn) Forecast By Route of Administration
  • 12.5 Market Value (US$ Mn) Forecast By Distribution Channel
  • 12.6 Market Attractiveness Analysis
    • 12.4.1 By Country
    • 12.4.2 By Drug Class
    • 12.4.3 By Route of Administration
    • 12.4.4 By Distribution Channel

Section-13 Latin America Nanoemulsion Market Analysis and Forecast

  • 13.1 Key Findings
  • 13.2 Market Value (US$ Mn) Forecast, By Country
    • 13.2.1 Brazil
    • 13.2.2 Mexico
    • 13.2.3 Rest of LATAM
    • 13.2.5 Rest of APAC
  • 13.3 Market Value (US$ Mn) Forecast By Drug Class
  • 13.4 Market Value (US$ Mn) Forecast By Route of Administration
  • 13.5 Market Value (US$ Mn) Forecast By Distribution Channel
  • 13.6 Market Attractiveness Analysis
    • 13.4.1 By Country
    • 13.4.2 By Drug Class
    • 13.4.3 By Route of Administration
    • 13.4.4 By Distribution Channel

Section-14 Latin America Nanoemulsion Market Analysis and Forecast

  • 14.1 Key Findings
  • 14.2 Market Value (US$ Mn) Forecast, By Country
    • 14.2.1 Saudi Arabia
    • 14.2.2 South Africa
    • 14.2.3 Rest of MEA
  • 14.3 Market Value (US$ Mn) Forecast By Drug Class
  • 14.4 Market Value (US$ Mn) Forecast By Route of Administration
  • 14.5 Market Value (US$ Mn) Forecast By Distribution Channel
  • 14.6 Market Attractiveness Analysis
    • 14.4.1 By Country
    • 14.4.2 By Drug Class
    • 14.4.3 By Route of Administration
    • 14.4.4 By Distribution Channel

Section-15 Competition Landscape

  • 15.1 Global Nanoemulsion Market Share Analysis, by Company (2016)
  • 15.2 Competition Matrix
  • 15.3 Company profiles
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Details
      • 15.3.1.2 Business Overview
      • 15.3.1.3 Financial Overview
      • 15.3.1.4 Strategic Overview
      • 15.3.1.5 SWOT Analysis
    • 15.3.2 Allergan plc.
      • 15.3.2.1 Company Details
      • 15.3.2.2 Business Overview
      • 15.3.2.3 Financial Overview
      • 15.3.2.4 Strategic Overview
      • 15.3.2.5 SWOT Analysis
    • 15.3.3 AstraZeneca
      • 15.3.3.1 Company Details
      • 15.3.3.2 Business Overview
      • 15.3.3.3 Financial Overview
      • 15.3.3.4 Strategic Overview
      • 15.3.3.5 SWOT Analysis
    • 15.3.4 Fresenius Kabi AG
      • 15.3.4.1 Company Details
      • 15.3.4.2 Business Overview
      • 15.3.4.3 Financial Overview
      • 15.3.4.4 Strategic Overview
      • 15.3.4.5 SWOT Analysis
    • 15.3.5 Kaken Pharmaceutical Co., Ltd.
      • 15.3.5.1 Company Details
      • 15.3.5.2 Business Overview
      • 15.3.5.3 Financial Overview
      • 15.3.5.4 Strategic Overview
      • 15.3.5.5 SWOT Analysis
    • 15.3.6 Mitsubishi Tanabe Pharma Corporation
      • 15.3.6.1 Company Details
      • 15.3.6.2 Business Overview
      • 15.3.6.3 Financial Overview
      • 15.3.6.4 Strategic Overview
      • 15.3.6.5 SWOT Analysis
    • 15.3.7 NanoBio Corporation
      • 15.3.7.1 Company Details
      • 15.3.7.2 Business Overview
      • 15.3.7.3 Financial Overview
      • 15.3.7.4 Strategic Overview
      • 15.3.7.5 SWOT Analysis
    • 15.3.8 Novartis AG
      • 15.3.8.1 Company Details
      • 15.3.8.2 Business Overview
      • 15.3.8.3 Financial Overview
      • 15.3.8.4 Strategic Overview
      • 15.3.8.5 SWOT Analysis
    • 15.3.9 GlaxoSmithKline plc.
      • 15.3.9.1 Company Details
      • 15.3.9.2 Business Overview
      • 15.3.9.3 Financial Overview
      • 15.3.9.4 Strategic Overview
      • 15.3.9.5 SWOT Analysis
    • 15.3.10 Sanofi
      • 15.3.10.1 Company Details
      • 15.3.10.2 Business Overview
      • 15.3.10.3 Financial Overview
      • 15.3.10.4 Strategic Overview
      • 15.3.10.5 SWOT Analysis
    • 15.3.11 B. Braun Melsungen AG
      • 15.3.11.1 Company Details
      • 15.3.11.2 Business Overview
      • 15.3.11.3 Financial Overview
      • 15.3.11.4 Strategic Overview
      • 15.3.11.5 SWOT Analysis

List of Tables

  • Table 01: List of Commercially Available Nanoemulsion
  • Table 02: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 03: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015-2025
  • Table 04: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 05: Global Nanoemulsion Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 06: North America Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015-2025
  • Table 07: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 08: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015-2025
  • Table 09: North America Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 10: Europe Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015-2025
  • Table 11: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 12: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015-2025
  • Table 13: Europe Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 14: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 15: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 16: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015-2025
  • Table 17: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 18: Latin America Nanoemulsion Market Size (US$ Mn) and Forecast, by Country, 2015-2025
  • Table 19: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 20: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015-2025
  • Table 21: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 22: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 23: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Drug Class, 2015-2025
  • Table 24: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Route of Administration, 2015-2025
  • Table 25: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025

List of Figures

  • Figure 01: Global Nanoemulsion Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 02: Market Revenue Share, by Drug Class (2016)
  • Figure 03: Market Volume Share, by Distribution Channel (2016)
  • Figure 04: Market Revenue Share, by Route of Administration (2016)
  • Figure 05: Market Volume Share, by Region (2016)
  • Figure 06: Global Nanoemulsion Market Value Share Analysis, Drug Class, 2017 and 2025
  • Figure 07: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Steroids, 2015-2025
  • Figure 08: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Anesthetics, 2015-2025
  • Figure 09: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by NSAIDs, 2015-2025
  • Figure 10: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Immunosuppressant, 2015-2025
  • Figure 11: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Antiretroviral, 2015-2025
  • Figure 12: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Antimicrobials, 2015-2025
  • Figure 13: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Vasodilators, 2015-2025
  • Figure 14: Global Nanoemulsion Market Size (US$ Mn) and Y-o-Y Growth, by Others, 2015-2025
  • Figure 15: Global Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 16: Global Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
  • Figure 17: Global Nanoemulsion Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Topical, 2015-2025
  • Figure 18: Global Nanoemulsion Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oral, 2015-2025
  • Figure 19: Global Nanoemulsion Market Value (US$ Mn) and
  • Figure 20: Global Nanoemulsion Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Nasal, 2015-2025
  • Figure 21: Global Nanoemulsion Market Value (US$ Mn) and
  • Figure 22: Global Nanoemulsion Market Attractiveness Analysis,
  • Figure 23: Global Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
  • Figure 24: Global Nanoemulsion Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2015-2025
  • Figure 25: Global Nanoemulsion Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2015- 2025
  • Figure 26: Global Nanoemulsion Market Revenue (US$ Mn) and Y-o-Y Growth (%), by E- Commerce, 2015-2025
  • Figure 27: Global Nanoemulsion Market Attractiveness Analysis,
  • Figure 28: Global Nanoemulsion Market Value Share Analysis, by Region, 2017 and 2025
  • Figure 29: Global Nanoemulsion Market Attractiveness Analysis,
  • Figure 30: North America Nanoemulsion Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 31: North America Nanoemulsion Market Size, Y-o-Y Growth Projection, 2017-2025
  • Figure 32: North America Nanoemulsion Market Attractiveness Analysis, by Country
  • Figure 33: North America Nanoemulsion Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 34: North America Nanoemulsion Market Value Share Analysis, by Drug Class, 2017 and 2025
  • Figure 35: North America Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 36: North America Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
  • Figure 37: North America Nanoemulsion Market Attractiveness Analysis, by Route of Administration, 2017-2025
  • Figure 38: North America Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
  • Figure 39: North America Nanoemulsion Market Attractiveness Analysis, by Distribution Channel, 2017-2025
  • Figure 40: Europe Nanoemulsion Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 41: Europe Nanoemulsion Market Size, Y-o-Y Growth Projection, 2017-2025
  • Figure 42: Europe Nanoemulsion Market Attractiveness Analysis, by Country
  • Figure 43: Europe Nanoemulsion Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 44: Europe Nanoemulsion Market Value Share Analysis, by Drug Class, 2017 and 2025
  • Figure 45: Europe Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 46: Europe Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
  • Figure 47: Europe Nanoemulsion Market Attractiveness Analysis, by Route of Administration, 2017-2025
  • Figure 48: Europe Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
  • Figure 49: Europe Nanoemulsion Market Attractiveness Analysis, by Distribution Channel, 2017-2025
  • Figure 50: Asia Pacific Nanoemulsion Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 51: Asia Pacific Nanoemulsion Market Size, Y-o-Y Growth Projection, 2016-2025
  • Figure 52: Asia Pacific Nanoemulsion Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 53: Asia Pacific Nanoemulsion Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 54: Asia Pacific Nanoemulsion Market Value Share Analysis, by Drug Class, 2017 and 2025
  • Figure 55: Asia Pacific Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 56: Asia Pacific Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
  • Figure 57: Asia Pacific Nanoemulsion Market Attractiveness Analysis, by Route of Administration, 2017-2025
  • Figure 58: Asia Pacific Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
  • Figure 59: Asia Pacific Nanoemulsion Market Attractiveness Analysis, by Distribution Channel, 2017-2025
  • Figure 60: Latin America Nanoemulsion Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 61: Latin America Nanoemulsion Market Size, Y-o-Y Growth Projection, 2017-2025
  • Figure 62: Latin America Nanoemulsion Market Attractiveness Analysis, by Country
  • Figure 63: Latin America Nanoemulsion Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 64: Latin America Nanoemulsion Market Value Share Analysis, by Drug Class, 2017 and 2025
  • Figure 65: Latin America Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 66: Latin America Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
  • Figure 67: Latin America Nanoemulsion Market Attractiveness Analysis, by Route of Administration, 2017-2025
  • Figure 68: Latin America Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
  • Figure 69: Latin America Nanoemulsion Market Attractiveness Analysis, by Distribution Channel, 2017-2025
  • Figure 70: Middle East & Africa Nanoemulsion Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 71: Middle East & Africa Nanoemulsion Market Size, Y-o-Y Growth Projection, 2017-2025
  • Figure 72: Middle East & Africa Nanoemulsion Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 73: Middle East & Africa Nanoemulsion Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 74: Middle East & Africa Nanoemulsion Market Value Share Analysis, by Drug Class, 2017 and 2025
  • Figure 75: Middle East & Africa Nanoemulsion Market Attractiveness Analysis, by Drug Class, 2017-2025
  • Figure 76: Middle East & Africa Nanoemulsion Market Value Share Analysis, by Route of Administration, 2017 and 2025
  • Figure 77: Middle East & Africa Nanoemulsion Market Attractiveness Analysis, by Route of Administration, 2017-2025
  • Figure 78: Middle East & Africa Nanoemulsion Market Value Share Analysis, by Distribution Channel, 2017 and 2025
  • Figure 79: Middle East & Africa Nanoemulsion Market Attractiveness Analysis, by Distribution Channel, 2017-2025
  • Figure 80: Global Nanoemulsion Market Heat Map Analysis By Company (2016)
Back to Top